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Abstract
Infective endocarditis (IE) at the right side represents the 5–10% of IE cases. It is
more frequent in people with intravenous drug addiction (IVDA); however, there is
another population susceptible to this infection; hemodialytic patients, intracardiac
devices, and congenital heart diseases are included inside this group. Right-sided
infective endocarditis (RSIE) has lower mortality than the left-sided infective
endocarditis (LSIE). Common symptoms secondary to right-sided endocarditis are
the respiratory symptoms characterized by a cough, hemoptysis, persistent fever,
dyspnea, and chest pain. Echocardiography and blood cultures are the first tools to
perform the diagnosis. The tricuspid valve is the main anatomical structure
affected. Medical treatment with antibiotic therapy resolves the infection majority
of the time; the surgical treatment is indicated in some cases, such as right-heart
failure due to severe tricuspid valve regurgitation; inability to eliminate bacteremia
or organism; resistance to culture-directed antibiotic treatment, within 7 days; and
tricuspid valve vegetations >20 mm. RSIE implies a better prognosis than LSIE.
Concomitant left-sided IE carries a worse prognosis than right-sided infection
alone, due predominantly to its greater likelihood for invasion and abscess
formation.
Keywords: infective endocarditis, right-sided infective endocarditis,
tricuspid valve, intravenous drug addiction, echocardiography, antibiotic, surgery,
hemodialysis, intensive care unit, pulmonary valve
1. Introduction
Infective endocarditis (IE) at the right side of the heart is quite rare; it represents
the 5–10% of IE cases. It is seen most frequently in people with intravenous drug
addiction; nevertheless, other portions of the population are in high risk of devel-
oping this disease such as patients with indwelling catheters, cardiac devices,
congenital cardiac pathologies, and immunocompromised diseases [1–3].
The evolution of right-heart IE is much better than the left-side IE with a lower
rate of mortality (3–30%) [3]. This pathology is more frequent in people between
20 and 61 years, with a mean age of 38  15 years [4].
Staphylococcus aureus is the predominant organism (60–90% of cases) with the
methicillin-resistant strains becoming more prevalent lately [3, 5]. The tricuspid
valve is by far the most effective structure (90%) in right-side infective endocardi-
tis (RSIE) [5].
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2. Diagnosis
2.1 Clinic manifestations
Common symptoms secondary to right-sided endocarditis are the respiratory
symptoms characterized by a cough, hemoptysis, persistent fever, dyspnea, and
chest pain [4].
In exceptional circumstances, right-heart failure can arise, generated by the
increase in pulmonary pressure, severe tricuspid valve regurgitation, or obstruction
of pulmonary circulation through multiple pulmonary emboli [4, 6].
The diagnosis of RSIE is often delayed because the signs and symptoms are
relatively different concerning the LSIE clinical setting; the Duke’s modified criteria
do not have value in the RSIE. The low incidence of RSIE also plays an essential
factor in the underdiagnosis of this disease.
There are reports in which the 76% of the patients had gotten an antibacterial
treatment before the endocarditis’s diagnosis because they developed some signs
and symptoms that were misunderstood as a febrile syndrome or pneumonia [4].
An acute beginning of the disease is seen at the majority of the patients; only a
few cases have been reported with chronic symptoms (more of 2 months) [4].
It is frequent that right-side vegetations dislodge microemboli to the pulmonary
region. The pulmonary embolism (PE) can induce pulmonary infarction, abscesses,
pneumothoraxes, and purulent pulmonary effusions.
Persistent fever associated with pulmonary events, anemia, and microscopic
hematuria, the so-called “tricuspid syndrome,” is the sign of clinical alert for tri-
cuspid valve IE [3, 4, 7].
Revilla et al. found 24% of their patients with this syndrome, and the other 65%
had at least two of the three signs [4].
2.2 Complementary exams
2.2.1 Laboratory
Nowadays it is routinary to order blood tests for any patient admitted at the
hospital, and it is reasonably used if the suspicion of infection is thought. Some
findings such as high titers of white blood cells, procalcitonin, and C-reactive
protein can support the infection diagnosis; nevertheless, these variables are not
used as criteria to diagnose infective endocarditis [5, 8].
The anemia has been described as part of the tricuspid syndrome, so the values of
hemoglobin and hematocrit below the normal range can be found in the blood test,
which probably will reveal a normocytic, normochromic anemia patron [3, 4, 7].
The urine test can show microhematuria which also is part of the tricuspid
syndrome.
2.2.2 Cultures
Right-sided endocarditis in IVDA is commonly caused by S. aureus and Pseudo-
monas aeruginosa, and other Gram-negative organisms, fungi, streptococci, and
enterococci have also been found [4, 6].
In the majority of patients, the microorganism can be identified through blood
cultures if they are adequately collected. The 2015 ESC endocarditis guidelines
recommend a technique of recollection minutely sterile of at least three sets of
samples with an interval of 30 minutes; each sample must contain 10 ml of blood
2
Infective Endocarditis
and should be incubated in both aerobic and anaerobic atmospheres. Another cru-
cial aspect is the recollection of samples from a peripheral vein instead of central
venous catheter due to the risk of contamination and wrong interpretation [5].
Occasionally, the blood cultures can be negative by different reasons, especially
if an antimicrobial therapy was established before the acquisition of the samples.
The blood cultures usually become negatives after 48 hours from the beginning of
antibiotics [4].
2.2.3 Image
Currently, the diagnosis of IE requires the finding of an infective process inside
the heart, reason why the imaging techniques are valuable to diagnose or discard IE.
The echocardiography is the most important and more used tool to diagnose, man-
age, and monitor patients with IE [5].
However, other imaging methods have been developed in the last decades,
allowing us to back the diagnosis of IE when the echography is not entirely clear in
some cases (Table 1).
2.2.3.1 Radiography
It can be quite normal or shows a variety of findings, such as cardiomegaly,
pulmonary septic emboli, or pleural effusion [4].
2.2.3.2 Echocardiography
The benefits that the echocardiography brought to the cardiology area are well-
known, and they can help us to detect anomalies related to IE. It is the gold standard
imaging test for IE, becoming one of the first steps that we must do if IE is
suspected [3, 9].
The same as the LSIE, the transthoracic echocardiography (TTE) is the first
modality recommended to perform if RSIE is suspected. The sensitivity of TTE to
detect vegetations is roughly 75% and its specificity over 90%. When the hunch of
IE is high, but the TTE is negative, the transesophageal echocardiography (TOE)
must be used because its sensitivity is higher than TTE, approximately 96%. Some
experts indeed recommend TOE even if the TTE is positive for IE; nevertheless,
it does not apply for RSIE in which an explicit finding of IE is enough for the
diagnosis [5, 9].
Table 1.
Imaging technique findings in the right-sided infective endocarditis.
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The 2015 ESC guidelines also suggest the use of TOE when the suspicion of IE is
present in patients with a prosthetic heart valve and intracardiac device [5].
There are some “typical lesions” of IE that we can detect in the echocardiogra-
phy, such as vegetations, abscess, pseudoaneurysm, valve aneurysm, perforation,
fistula, and dehiscence of the prosthetic valve, being the vegetation of the landmark
lesion of this disease (Figure 1) [5, 9].
Occasionally, parts of the vegetations can be visualized floating in the right
ventricle or entrapped in the subvalvular apparatus. TTE usually allows assessment of
tricuspid valve involvement because of the valve’s anterior location and large natural
vegetations. TOE imaging is more sensitive to detect vegetations than TTE imaging,
especially in the case of abscesses, and associated left-sided involvement [6].
2.2.3.3 Computed tomography (CT)
Cardiac computed tomography (CCT) can improve the diagnosis of IE when
abscesses and pseudoaneurysm are present, due to its higher sensitivity (approxi-
mately 81%) in comparison with TTE and TOE (roughly 63%). The combination of
echocardiography and CCT to diagnose abscess/pseudoaneurysm reaches 100%
sensitivity. In pulmonary/right-sided endocarditis, CT may reveal concomitant
pulmonary disease, including abscesses and infarcts [5, 10].
2.2.3.4 Magnetic resonance (MR)
The use of MR in the IE setting is focused on the diagnosis of cerebrovascular
events related to IE. This imaging modality has better sensitivity than CT to detect
brain hemorrhage and infectious intracranial aneurysms (IIAs) [5, 11].
2.2.3.5 Nuclear imaging
The incorporation of positron-emission tomography (PET) in the modified
Duke’s criteria is addressed to enhance the IE diagnosis in some situations where the
Figure 1.
Transesophageal echocardiogram: a hyperechoic lesion (red arrow) is seen at level of pulmonary valve,
prolapsing to right ventricle outflow tract.
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clinical suspicion is not always confirmed with the echocardiography. This imaging
technique is especially valuable in the diagnosis of prosthetic valve infective endo-
carditis (PVIE) [5, 12].
There are also reports where the PET helped to determine the extension of
pacemaker or defibrillator infection, consequently improving the adequate surgical
intervention [13].
Peripheral embolic and metastatic infectious events can also be detected with
this technique; nevertheless, their specificity is lower in brain septic emboli [5].
A correct interpretation of PET must be taken in some conditions which can make
us misinterpret the findings, for instance, a recent cardiac surgery usually shows
enhancement at the mediastinal area due to the inflammatory response. Some condi-
tions can show similar patterns to that of IE, such as an active thrombus, soft
atherosclerotic plaques, vasculitis, primary cardiac tumors, cardiac metastasis from a
non-cardiac tumor, postsurgical inflammation, and foreign body reactions [5].
3. Treatment
3.1 Medical treatment
The same fundamental aspects about the antibiotic therapy in IE is applied to the
right-sided endocarditis, making emphasis in the early and proper setting of the
cultures, the prompt and adequate starting of empirical antimicrobial therapy (if
the suspicious of IE is higher), and the administration of a culture-antibiogram
sensible antibiotic.
One aspect that changed in the antimicrobial treatment of RSIE in comparison
with LSIE is the duration of the therapy when the implicated bacteria is the
methicillin-sensible Staphylococcus aureus, due to the 2015 European Society of
Cardiology guidelines for the management of infective endocarditis recommending
a short treatment of 2 weeks in this scenario. This approach is attributed to the less
aggressive evolution of RSIE with these bacteria [5].
The prophylactic treatment in the patient with high suspicion of RSIE should
cover Staphylococcus aureus, streptococci, and enterococci and should include
penicillinase-resistant penicillins or vancomycin, depending on the local prevalence
of methicillin-resistant Staphylococcus aureus (MRSA) [6].
3.2 Surgery treatment
In RSIE, the medical treatment usually resolves the disease; nevertheless, the
surgery for right-sided infective endocarditis is recommended in the following
situations: (1) right-heart failure due to severe tricuspid valve regurgitation,
(2) inability to eliminate bacteremia or organisms resistant to culture-directed anti-
biotic treatment, within 7 days, and (3) tricuspid valve vegetations >20 mm [1–3, 5].
During the surgery, most of the infected tissue must be removed; if it is possible,
we should try to repair the native valve but guarantee the adequate functioning of
the valve. When a valve-sparing is impossible, the implantation of a prosthetic
valve is necessary, always trying to use the less foreign material to diminish the risk
of IE recurrence [14].
Sometimes the endocardial destruction is highly extensive that compromises the
valve repairing as well as the valve prosthesis replacement; this scenario is hideous
and requires the reconstruction of the annular structure using endocardium patch
or other materials.
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Another potential complication of IE can be the formation of ventricular septal
defect due to the infection’s aggressiveness which can show communication
between the right ventricle and left ventricle through the membranous septum.
This anatomical defect also can be figured out with a pericardium patch [15].
Some surgeons can feel uncomfortable with the idea of setting up a prosthetic
valve in tricuspid position due to being afraid of high gradients through the valve
and the potential thrombosis of the prosthesis. However, large prostheses
(>30 mm) guarantee low transvalvular gradients, and the incidence of thrombosis
is small if the patient has an adequate anticoagulation control (biological and
mechanic prostheses are anticoagulated). Moreover, bioprosthesis degeneration
develops more slowly owing to the low-pressure conditions in the right ventricle [6].
In 1991, Arbulu et al. published a paper showing their experience in tricuspid
valvulectomy without replacement, generally indicated for IVDA, to avoid the
potential IE recurrence; nevertheless, about 25% of patients cannot tolerate tricus-
pid regurgitation and require a second operation for tricuspid valve replacement
[14, 16].
4. Prognosis
RSIE implies a better prognosis than LSIE; the previous study revealed the
mortality of right-sided IE is 12% in-hospital patients and 0–7.3% for surgical
patients. However, these percentages increase at least twice in patients with inten-
sive care unit (ICU) admission; actually, this issue will be described forward [3, 9].
Concomitant left-sided IE carries a worse prognosis than right-sided infection
alone, due predominantly to its greater likelihood for invasion and abscess
formation [7].
5. Prevention
The high increase of bacterial resistance throughout the last decades has
produced a change in the IE guidelines from 2002. The same criteria for LSIE are
applied to RSIE regarding the antimicrobial prophylaxis, being reserved only in
patients with a high risk of endocarditis, particularly those with PVIE [5].
Nevertheless, there are some aspects that the last IE guidelines do not approach
which are very relevant that need to be highlighted. One of the most critical issues is
the quite strict aseptic measurements that healthcare professionals must take during
routine procedures, especially invasive maneuvers in high-risk patients such as
immunocompromised, hemodialytic (HD), cyanotic congenital heart disease
(CHD) patients, etc.
The change in some hospital policies can diminish the incidence of bacteremia
and IE, such as have been shown in some publications [17].
6. RSIE in intensive care units (ICU)
There are few publications about the characteristics of RSIE in ICU. It is note-
worthy that patients with IE admitted in ICU have a higher rate of morbidity and
mortality than non-ICU patients. The only study describing the outcome of IDUs
with RSIE needing ICU admission reported a mortality of 26% [2].
Some factors have been associated with a worse prognosis: acute respiratory
failure requiring mechanical ventilation, shock, Simplified Acute Physiology Score
(SAPS II) ≥ 20, and Sequential Organ Failure Assessment (SOFA) ≥ 3 [2, 5].
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Other elements that play an essential role at the 30-day survival are age
<45 years, Charlson score < 3, endocarditis diagnosed before ICU admission,
aminoglycoside use, the presence of septic pulmonary embolism, and a single
surgical indication for patients needing a surgical procedure [2].
Reasons for admission to the ICU were a congestive cardiac failure (64%), septic
shock (21%), neurological deterioration (15%), and cardiopulmonary resuscitation
(9%). Younger patients have a better prognosis because they usually present a
minimal dysfunction of the right-sided valve, low risk of pulmonary embolism, and
reasonable response to appropriate antibiotic therapy [2].
Opposite to the last IE guidelines, which no longer recommend the
aminoglycosides in the treatment of native valve staphylococcal endocarditis,
Georges et al. found a better survival in their patients treated with a combination of
penicillins or vancomycin with gentamicin [2].
7. Risk factors
It is imperative to describe this pathology in the people with susceptible risk
factors (Table 2).
7.1 RSIE in people with intravenous drug addiction (IVDA)
The majority of cases of RSIE reports in the literature are in drug abusers. This
kind of populations of RSIE represents the 32–86% of all IE [2, 3].
There are multiple explanations about the preference of infection in the right
side of the heart at this group of the population, being the leading causes of the poor
hygiene with unsafe injection practices and the affected immunology well-being.
The higher bacterial load and the variety of effects of injected substances over the
endocardium also play an essential role in the physiopathology of the infection [7].
AVF: arteriovenous fistula, HD: hemodialytic, HIV: human immunodeficiency virus, IE: infective endocarditis, RSIE:
right-sided infected endocarditis, VSD: ventricular septal defect.
Table 2.
Characteristics of principal risk factors in the right-sided infective endocarditis.
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The incidence of reinfections and reoperations is about 28 and 20%, respec-
tively; however, the survival described in some papers is almost equal between drug
abusers and not drug abusers, in which results are very striking [7].
Sometimes IVDA also presents human immunodeficiency virus (HIV) which
can aggravate the predisposition to IE if this disease is not well-controlled. The
death rates in this subgroup of patients are about 5–10% [1]. The HIV affects both
humoral and cellular immunities which provoked a predisposition for recurrent
episodes of bacteremia that cause valve damage, fibrin deposition, thrombus for-
mation, and adherence by bacteria in the endocardium; it is common to find abscess
developments and large vegetations, which are indications for early surgical
treatment [18].
The choice of empiric antimicrobial therapy depends on the suspected microor-
ganism and type of drug and solvent used by the addict and the location of
infection.
As previously was described, the empirical antimicrobial therapy must cover
S. aureus; the combination of penicillinase-resistant penicillins or vancomycin or
daptomycin with gentamicin is recommended [5].
The 2015 ESC IE guidelines recommend an antipseudomonal therapy in patients
with pentazocine addiction if IE is suspected; nevertheless, there are few and
relatively old studies about this issue [5, 19, 20].
If an IVDA uses brown heroin dissolved in lemon juice, Candida spp. (not
Candida albicans) should be considered and antifungal treatment added [5].
7.2 RSIE in people with no IVDA
Although the majority of IE at the right side of the heart is fairly reported in
IVDA, there is an increasing incidence in another type of patients, mainly
highlighting the people with indwelling catheters and cardiac devices. The 5–10% of
RSIE occur in nonaddicted patients [3].
7.2.1 Indwelling catheters
It is estimated that more than 3 million people worldwide require dialysis for
end-stage renal disease, and this number is expected to rise sharply because of the
aging of the population and an increasing prevalence of diabetes and cardiovascular
comorbidities paralleled by a decline in cardiovascular mortality, particularly in
very elderly patients (>80 years). For instance, in the United States, this augmen-
tation is about 3.2% per year [21, 22].
Hemodialysis patients are at increased risk for bacteremia, including an esti-
mated 37,000 central line-associated bloodstream infections related to outpatient
hemodialysis in the United States in 2008. The elevated incidence of bacteremia
increases the risk for infective endocarditis [22, 23].
The average duration on HD before the diagnosis of IE was 30 months (range,
4–66 months). IE is one of the most important causes of increased mortality and
morbidity among hemodialysis patients [24].
The European Heart Journal states that more than two-thirds of patients under-
going hemodialysis suffer from some infection and that one-third of these patients
experience IE [24].
IE occurs 18 times more frequently in chronic HD patients than in the general
population [25, 26].
The use of temporal or permanent central catheters, the constant puncture of
arteriovenous fistulas, the long and frequent hospitalizations that some of these
patients have to suffer during their disease, the various surgical procedures related
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with the creation of fistulas, and the underlying alteration of their defenses become
susceptible to this population to develop IE.
The IE in HD patients is calculated about at 8% of all observed IE cases regarding
the largest international cohort collected to date [27].
The incidence of IE usually increases with the time after the initiation of hemo-
dialysis; however, some studies found a rise of this incidence in the first 5 months
after the initiation of hemodialysis [26, 28]. This contradictory results can be prob-
ably due to the aseptic technique during the manipulation of the catheter and
arteriovenous fistulas of these patients.
Patients in HD also present an increase in the incidence of endocarditis after
aortic valve replacement surgery, affecting at the same time the short-term and
long-term survival [22].
Most of the studies show that central catheters are a risk factor for bacteremia
and endocarditis [6, 7, 10]; nevertheless, Farrington et al. did not find an increase of
endocarditis in patients with central catheters in comparison with patients with
arteriovenous fistulas [22].
Besides, the rates of IE are more significant in patients with non-cuffed catheters
than cuffed catheters; the vascular grafts have more incidence of IE than AV
fistulas. Furthermore, peritoneal dialysis has then lesser rates of IE due to the lack of
contact of the line with luminal vessels [29].
The morbidity and mortality are higher than the general population; in the 20%
of hemodialysis-related IE, the tricuspid valve is the principal place affected at the
right side of the heart.
The pathogenesis of IE in HD patient can be attributed to recurrent episodes of
bacteremia, the immunological compromise of hemodialytic patients and heart
valvular deterioration-calcification frequently founded in this patients.
It can sound logical that the majority of cases of IE in HD patients should happen
on the right cavities, similar to what occurs in IVDA; however, the left-side heart
(90%) is the more frequent infected place in HD patients, the mitral being the main
valve affected. The affectation of the right cavities is roughly 10%. Nevertheless,
some papers report an incidence of RSIE in HD patients of between 0 and 50%
[30, 31].
Between the multiple explanations of pathogenesis RSIE in HD patients, the high
turbulent flow throughout the valves can provoke a deterioration at these structures,
becoming more susceptible to bacterial implantation. Nonetheless, the low pressures
at the right cavities might not present the same effect in their valves. One possible
cause can be the associated pulmonary hypertension that some patients express, due
to multiple factors, such as an increased cardiac output (hypervolemic condition and
arteriovenous fistula), an increased pulmonary vascular resistance (uremic endothe-
lial dysfunction and pulmonary artery calcifications), and elevated pulmonary capil-
lary wedge pressure caused by heart failure or mitral valve disease [17].
7.2.1.1 Prevention
Patients in HD have an increased risk of developing IE due to all the reasons
described before, so to take some measurements sounds logical to diminish the
incidence of bacteremia which can result in an IE.
In some hospitals, their politics have been changed regarding the hemodialysis
procedure with the intention to ameliorate the arteriovenous life expectancy and
decrease the local and systemic infections. For instance, Oun HA et al. have published
a lowering in the bacteremia and IE at his hospital adopting new strategies, such as
changing the lock solution to taurolidine, cleaning the puncture site with chlorhexi-
dine 2%, and using the buttonhole technique instead of the rope ladder technique.
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Nonetheless, it is important to mention that the buttonhole technique had a modest
but not significative rising of bacteremia following the move to buttonhole [26].
The arteriovenous fistula (AVF) must always be the best option to perform HD
due to their low rates of bacteremia and IE, so, it is imperative to develop an
adequate surgical technique and improve the care of the fistula. Whenever it is
possible, the fistula must be carried out at the distal part of the arms, trying to
preserve the proximal areas to future AVF if the distal fistula fails at some point. If
the HD needs a temporary or permanent catheter, the cuffed ones always are
preferable to non-cuffed catheters, because the former cause fewer rates of IE [29].
The patient and healthcare personnel must be informed and trained regarding the
proper care of the AVF and catheters to lower the probability of bacteremia and IE.
The cleaning of the surgical area is paramount as well as the correct AVF puncture.
7.2.2 Intracardiac devices (ICD)
Nowadays ICD are widely used worldwide; their implementation in the cardiol-
ogy area has improved the quality of life of many people and increased the survival;
nonetheless, they have side defects, the endocarditis being one of the most severe
complications.
The IE on a cardiac device is increased in the last 10 years in the first-world
countries, even becoming the most common cause of IE in some regions. This
phenomenon is caused mainly by the rise in the longevity in these countries which
results in a growing number of intracardiac devices implanted (pacemakers, cardiac
defibrillator, cardiac resynchronizer, or ventricle assist device) [32].
This IE is associated with a worse prognosis and high mortality (11–36%)
[32–34]. The pacemaker generator or lead change is the higher factor of risk for IE
on the cardiac device. The tricuspid valve is the most common site of RSIE associ-
ated with this kind of devices [7, 35].
The removal of the infected device is mandatory in the treatment of intracardiac
device infective endocarditis (ICDIE) because it decreases the hospital mortality
[32]. Patients with device-related infection and intracardiac vegetations higher or
equal at 1 cm have historically undergone surgery for device removal due to the
potential risk for septic embolization [34].
7.2.3 Congenital heart disease (CHD)
The risk of IE in patients with adult congenital heart disease (ACHD) is sub-
stantially higher (15–140 times) than in the general population. The RSIE in CHD is
more often in adults than pediatric patients [5, 36].
The ventricular septal defect (VSD) is the most frequent anomaly in right-sided
IE with an incidence of 0.2–2% of all IE [37].
The risk of IE can occur either in repaired or not repaired VSD, with a higher
increase in the last one [38].
A recent paper from Tutarel et al. found an incidence of 15.9% of IE in patients
with VSD; the 50% of these cases were associated with infections of either the
tricuspid valve or the right ventricular outflow tract [36].
The 2015 ESC IE guidelines describe that the distribution of causative organisms
does not differ from the pattern found in acquired heart disease, with streptococci
and staphylococci being the most common strains. Another study found the strep-
tococci responsible for 50% of congenital heart disease infective endocarditis
(CHDIE) and the staphylococci with a 31% incidence [5, 36].
The pulmonary valve is affected in almost 32% of patients from which over an
84% are prosthetic and near 16% native valve [36].
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8. Locations
Unlike the left-sided IE mainly occurring on the aorta or mitral valve, right-
sided IE could involve the tricuspid valve (82%), pulmonary valve, eustachian
valve, interventricular septum, right ventricular free wall, or CS [4, 9].
8.1 Tricuspid valve (TV)
The vast majority of RSIE cases involve the TV (approximately 90%). The high
risk of vegetations on the TV is septic PE resulting in various pulmonary complica-
tions such as pneumonia and pulmonary abscess.
Uncomplicated tricuspid valve endocarditis can be successfully treated medi-
cally in 80% of patients and in the remaining 20% with very large vegetations and
expectably poor antibiotic penetration [6].
The infection of the native tricuspid valve in nonaddicted adults occurs in
younger patients (under 50 years). In the majority of cases (70%), there are under-
lying medical conditions such as alcoholism, abortion, colon disease, immunodefi-
ciency, permanent catheters, septic processes in the oral cavity, skin, or genitals,
etc. The 25% of cases require valve replacement or surgery [3] (Figure 2).
8.2 Pulmonary valve (PV)
RSIE in PV happens in less than 10% of the patients [7]. Most of the cases of
pulmonary valve infective endocarditis (PVIE) are provoked by prosthetic material
present at this place due to previous surgeries or interventional procedures focused
on figuring a congenital disease out.
Bovine jugular grafts are associated with a significantly higher risk of late endo-
carditis compared with homografts [39].
However, Robichaud et al. did not find an increased risk of PVIE regarding the
type of valve, including bovine jugular vein grafts [40].
The rate of IE in transcatheter pulmonary valve implantation is higher than
surgical homograft implantation [41].
Figure 2.
Pulmonary native endocarditis: a giant mass anchored to the posterior leaflet of pulmonary valve [42].
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8.3 Other sites
Uniquely few case reports have been published about RSIE in other locations
different to tricuspid and pulmonary valves.
8.3.1 Eustachian valve
Reports of eustachian valve infective endocarditis (EVIE) are approximately 29
cases [43]. An incidence of 3.3% in patients with right-sided endocarditis has been
reported [44].
Eustachian valve is a rudimentary structure in adults and, during fetal life,
directs oxygenated blood from the inferior vena cava through the foramen ovale
and into the left atrium [43, 45].
IVDA is the main high-risk population to develop an EVIE (over 50% of cases).
Staphylococcus aureus is the most common bacteria implicated in this process [43].
TOE is necessary to identify the vegetation at eustachian valve because this struc-
ture is not accessible with TTE [45].
8.3.2 Coronary sinus
There are only eight reported cases of IE in the coronary sinus (CS). The clinical
manifestations, the complementary test, the responsible bacteria, and antibiotic
treatment are very similar to the other RSIE locations. The CSIE has some features;
the CS is always dilated and generally the only affected valve; the vegetation is
usually mobile and has a tubule shape with a length of >10 mm [9, 46].
9. Conclusions
RSIE is a pathology scarcely studied because there are few articles released about
it. One of the significant reasons about the RSIE little information is the low inci-
dence of this disease; nevertheless, the rates of frequency of this infection are rising
nowadays due to the steady increase of HD patients and implanted ICD.
• RSIE clinic criteria are necessary to establish to help in the diagnosis of the
disease, such as modified Duke criteria.
• Healthcare personnel must be aware of this illness, keeping their suspicion in
high-risk patients and performing the proper complementary test to confirm
or discard this infection.
• Hospital policies should be continuously updated to diminish the incidence of
RSIE, an adequate epidemiologic analysis about RSIE cases, the population in
potential risk to acquire the infection, and the most frequent bugs implicated in
this one.
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Nomenclature
ACHD adult congenital heart disease
AVF arteriovenous fistula
CHD congenital heart disease
CHDIE congenital heart disease infective endocarditis
CS coronary sinus
CT computed tomography
EVIE eustachian valve infective endocarditis
HD hemodialytic
HIV human immunodeficiency virus
ICD intracardiac devices
ICU intensive care unit
IE infective endocarditis
IIAs infectious intracranial aneurysms
IVDA intravenous drugs addiction
LSIE left-side infective endocarditis
MRSA methicillin-resistant Staphylococcus aureus
MR magnetic resonance
PET positron-emission tomography
PE pulmonary embolism
PVIE prosthetic valve infective endocarditis
PV pulmonary valve
RSIE right-side infective endocarditis
SAPS Simplified Acute Physiology Score
SOFA sequential organ failure assessment
TTE transthoracic echocardiography
TOE transesophageal echocardiography
TV tricuspid valve
VSD ventricle septal defect
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